The 15 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 92.00, with a high estimate of 107.00 and a low estimate of 84.00. The median estimate represents a +13.71% increase from the last price of 80.91.
The current consensus among 16 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.41
Reporting Date Oct 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.